OB/GYN Clinical Alert – February 1, 2011
February 1, 2011
View Issues
-
Rivaroxaban: A Fixed-dose Regimen for Anticoagulation
This paper presents two parallel studies that evaluate the safety and efficacy of oral rivaroxaban in the treatment of acute deep venous thrombosis (DVT) and in continuing prophylaxis for recurrence. -
The IUD: An Upstream Battle to Clear Its Name
Lewis and colleagues performed an investigator-blinded study of sperm penetrability and quality of mid-cycle cervical mucus between levonorgestrel-releasing intrauterine device (LNG-IUD) users (n = 14) and hormone-free controls (n = 16). -
Early Delivery: Neonatal Outcomes After Demonstrated Fetal Lung Maturity Before 39 Weeks of Gestation
The pendulum has been swinging away from doing early deliveries without indications, but the question remains: What is early? -
Are Procedural Complications Related to Sleep Pattern the Night Before?
Conducted in a 700+ bed tÿ -
Are Procedural Complications Related to Sleep Pattern the Night Before?
Conducted in a 700+ bed tertiary care, urban academic teaching hospital with a trauma center and referral center for high-risk obstetrics, this retrospective cohort study involved the procedures of 86 surgeons and 134 OB/GYNs between 1999 and 2008. -
Single Umbilical Artery: Need for Specialist Fetal Echocardiography
A Single Umbilical Artery (SUA) is found in about 1 in 200 fetuses in the second trimester. Since the finding is associated with an increase in fetal anomalies, it alerts clinicians to search for any of the possible abnormalities linked with this finding. -
Complications of Products Developed to Prevent Complications
Intraoperative placement of adhesion barriers has been a long-practiced adjuvant to major abdominal/pelvic surgery in an attempt to reduce postoperative complications such as bowel obstruction and infertility. -
Pharmacology Watch: Statin Use in Patients with Abnormal Liver Function
In this issue: Statins and liver function; dosing timing for thyroxine; rivaroxaban for VTE, DVT, and stroke; echinacea and the common cold; and FDA actions. -
Clinical Briefs in Primary Care supplement